CH ENV TECH&BIO: Interim Report 2024
ch env tech&bio (01237.HK) saw a slight increase of 4% in mid-year earnings to 0.1865 billion yuan.
Ch env tech&bio (01237.HK) announced on August 30 that the group's income for the six months ended June 30, 2024, slightly increased by 4% to 18.65 million yuan compared to the same period last year. During the period, the group's gross margin was 7.2% (first half of 2023: 12.1%). The group's gross profit was 13.4 million yuan (first half of 2023: 21.7 million yuan).
CH ENV TECH&BIO: 2024 INTERIM RESULTS ANNOUNCEMENT
In the profit warning, Ch Env Tech&Bio (01237.HK) is estimated to have a loss of 2 million RMB in the first half of the year.
Ch env tech&bio (01237.HK) issued a profit warning, expecting a loss of 2 million yuan for the six months ending in June, compared to a profit of 2.7 million RMB in the same period last year. This is mainly due to the decline in gross margin of sales.
ch env tech&bio (01237) issued a profit warning, expecting a net loss of approximately 2 million yuan in the medium term.
ch env tech&bio (01237) announced that compared to the net surplus earned for the six months ended June 30, 2023...
Ch Env Tech&Bio (01237.HK): Wu Liping was appointed as an independent non-executive director.
On July 29th, Ge Long Hui reported that Ch Env Tech&Bio (01237.HK) announced that, effective July 29th, 2024: (1) Jin Zhongwei resigned as an independent non-executive director, chairman of the company's remuneration committee and nomination committee, as well as a member of the company's audit committee and risk management committee; (2) Su Wenqiang resigned as an independent non-executive director, member of the remuneration committee, nomination committee, audit committee and risk management committee; (3) Wu Liping was appointed as an independent non-executive director, chairman of the remuneration committee, and a member of the nomination committee, audit committee and risk management committee; (4) Zheng Bingqian was appointed as an independent
Express News | *ST Ningke: The company and its subsidiaries have not received court documents to accept pre-restructuring and restructuring
CH ENV TECH&BIO: 2023 ANNUAL REPORT
Zhongke Biotech (01237) grants 3.9 million bonus shares
Zhongke Biotech (01237) issued an announcement. On April 15, 2024, in accordance with the terms of the share award plan...
Zhongke Biotech (01237) announced annual results. Losses attributable to shareholders of 2.364 million yuan narrowed by 63.95% year-on-year
According to Zhitong Finance App, Zhongke Biotech (01237) announced its annual results for the year ended December 31, 2023. The group achieved revenue of 298 million yuan (RMB, same below), a year-on-year decrease of 36.02%; shareholders' losses of 2.364 million yuan, a year-on-year narrowing of 63.95%; the basic loss per share was 0.03 yuan; the announcement stated that in the reporting year, wood products revenue was still the Group's largest source of revenue. Revenue in this category fell 36.0% to $295 million (2022: $461 million), accounting for 99.2% of total sales for the reporting year (2022:99.1 million)
CH ENV TECH&BIO: ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Zhongke Biotech (01237) issued a profit warning. The annual net loss is expected to decrease by about 65% year on year
Zhongke Biotech (01237) announced that the Group expects to achieve net results for the year ending December 31, 2023...
CH ENV TECH&BIO: PROFIT WARNING
Zhongke Biotech (01237.HK) held a board meeting on March 28 to approve annual results
Gelonghui March 15 | Zhongke Biotech (01237.HK) announced that the company will approve the annual results announcements of the company and its subsidiaries for the year ended December 31, 2023 for publication at the board meeting to be held on March 28, 2024, and is expected to implement the dividend payment proposal (if any) and handle other matters.
Express News | Ningke Biotech was forced to take 110 million
China Environmental Technology to Award 39 Million Shares Under Incentive Scheme
Zhongke Biotech (01237.HK) granted a total of 39 million reward shares
Gelonghui November 14|Zhongke Biotech (01237.HK) announced that on November 14, 2023, the company's board of directors decided to award a total of 39 million reward shares to 10 selected participants in accordance with the share reward plan. The Board believes that awarding the selected participants 2023 reward shares to provide rewards to the selected participants and will allow the Group to attract, retain and motivate talents for its continued operation and development. The awarding of 2023 reward shares to selected participants is in recognition of their continued support, which is equal to the Group's continued support, and their efforts will contribute to the Group's future development.
CH ENV TECH&BIO To Carry Out 1-for-10 Reverse Stock Split On January 2nd, 2024
November 4th - $CH ENV TECH&BIO(01237.HK)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from January 2nd, 2024.$CH ENV TECH&B
China Environmental Technology Plans 10-For-1 Share Consolidation
CH ENV TECH&BIO: Interim Report 2023
No Data
No Data